Udvalget for Humanmedicinske Lægemidler (CHMP) besluttede, at fordelene ved Tadalafil Lilly var større end risiciene ved behandling af mænd med erektil dysfunktion.
The Committee for Medicinal Products for Human Use (CHMP) decided that Tadalafil Lilly’ s benefits are greater than its risks for the treatment of men with erectile dysfunction.